MARKET

ETON

ETON

Eton Pharmaceuticals
NASDAQ
64.35
+7.89
+13.97%
Pre Market: 56.06 -8.29 -12.88% 04:00 11/10 EST
OPEN
58.10
PREV CLOSE
56.46
HIGH
64.44
LOW
57.02
VOLUME
2
TURNOVER
0
52 WEEK HIGH
66.37
52 WEEK LOW
14.27
MARKET CAP
1.86B
P/E (TTM)
166.84
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ETON last week (1102-1106)?
Weekly Report · 1d ago
Eton Pharmaceuticals Earnings Call Highlights Record Growth
TipRanks · 3d ago
Eton Pharmaceuticals Is Maintained at Buy by Canaccord Genuity
Dow Jones · 3d ago
Eton Pharmaceuticals Price Target Raised to $80.00/Share From $68.00 by Canaccord Genuity
Dow Jones · 3d ago
Canaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $80
Benzinga · 3d ago
Eton Pharmaceuticals Stock Gains as 3Q Revenue More Than Doubles
Dow Jones · 3d ago
Eton Pharma jumps after Q3 beat and guidance hike
Seeking Alpha · 3d ago
Eton Pharmaceuticals Price Target Raised to $80.00/Share From $70.00 by HC Wainwright & Co.
Dow Jones · 3d ago
More
About ETON
Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company has over 11 commercial rare disease products: KHINDIVI, INCRELEX, ALKINDI SPRINKLE, DESMODA, GALZIN, HEMANGEOL, PKU GOLIKE, IMPAVIDO, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has four additional product candidates in late-stage development: Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjectors. INCRELEX (mecasermin) is used to treat children who are very short for their age because their bodies do not make enough insulin-like growth factor-1 (IGF-1). ALKINDI SPRINKLE is for the treatment of pediatric adrenocortical insufficiency. NITISINONE is a prescription medicine used to treat adults and children with a hereditary disease called tyrosinemia type 1 (HT-1). The Company also has licensed United States rights to a rare disease product candidate ASN-001 (timolol topical gel).

Webull offers Eton Pharmaceuticals Inc stock information, including NASDAQ: ETON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ETON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ETON stock methods without spending real money on the virtual paper trading platform.